is a popular prescription anxiety medication being remembered across the country For a “possibly life-threatening” mistake on the carton.
Pennsylvania-based pharmaceutical manufacturer Endo announced this week This is expanding the scope of the recall of Clonazepam tablets because some containers are labeled with the wrong drug strength and the wrong drug code.
The new recall affects 16 lots of Clonazepam Orally Disintegrating Tablets, USP (C-IV), in dosages ranging from 0.125 mg to 2 mg. The package contains 10 blister strips each containing six tablets. They are scheduled to expire between August 2026 and February 2027.
Clonazepam is a benzodiazepine used to treat anxiety problem and certain types of seizures,
Endo warns that taking high doses of clonazepam may increase the risk of drowsiness, confusion, dizziness, decreased responsiveness, and loss of muscle control or strength.
There is also a risk of “significant, possibly life-threatening” trouble with breathing, especially for people with respiratory disease, who have been prescribed the maximum dose and who are taking other medicines that affect breathing.
Endo reports that as of Monday, it has received no reports of problems resulting from the recall. pharmaceutical company Announced its initial comeback in July Just one lot of Clonazepam.
At the time, Endo attributed the mislabeling to an “error in the third-party packager.”
Some cartons showed the strength of the product as 0.125 mg, not 0.25 mg. Blister strips inside the package indicate the correct strength, Endo said.
Par Pharmaceutical of New York is also listed as a distributor of the recalled cans. The Chestnut Ridge-based company marketed clonazepam before Endo acquired the product.
People who have questions about the recall should call (855) 589-1869 or email rxrecalls@inmar.com,
Retailers carrying these products are being instructed not to sell them, while consumers should not consume them. If you think you have taken the wrong dose of clonazepam, consult a doctor.
